These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10719313)

  • 1. Trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients: long-term follow-up regarding efficacy and safety.
    Demoly P; Messaad D; Reynes J; Faucherre V; Bousquet J
    J Allergy Clin Immunol; 2000 Mar; 105(3):588-9. PubMed ID: 10719313
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection.
    Belchi-Hernandez J; Espinosa-Parra FJ
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F
    Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
    Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
    Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of desensitization for reintroducing trimethoprim-sulfamethoxazole in hypersensitive patients with HIV infection].
    Caumes E
    Ann Med Interne (Paris); 1997; 148(2):172-6. PubMed ID: 9238444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini-dose trimethoprim with sulphamethoxazole prevents pneumocystis and toxoplasmosis infections after heart transplantation.
    Keogh A; Macdonald P; Richens D; Harvison A; Spratt P
    Transplant Proc; 1992 Oct; 24(5):2263. PubMed ID: 1413049
    [No Abstract]   [Full Text] [Related]  

  • 7. [Frequent side effects of cotrimoxazole in persons infected with HIV, possibly due to metabolites of sulfamethoxazole].
    van der Ven AJ; Koopmans PP; Vree TB; van der Meer JW
    Ned Tijdschr Geneeskd; 1992 Jan; 136(2):61-3. PubMed ID: 1732828
    [No Abstract]   [Full Text] [Related]  

  • 8. Life-threatening reaction to trimethoprim/sulfamethoxazole in pediatric human immunodeficiency virus infection.
    Chanock SJ; Luginbuhl LM; McIntosh K; Lipshultz SE
    Pediatrics; 1994 Mar; 93(3):519-21. PubMed ID: 8115221
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug hypersensitivity in AIDS patients: report of a case].
    Ribeiro LM; Pastorino AC; Grumach AS; Jacob CM
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(1):23-7. PubMed ID: 9334468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly diagnosed human immunodeficiency virus after sepsis-like reaction of trimethoprim-sulfamethoxazole.
    Moran KA; Ales NC; Hemmer PA
    South Med J; 2001 Mar; 94(3):350-2. PubMed ID: 11284528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restarting trimethoprim-sulfamethoxazole after a hypersensitivity reaction in patients infected with the human immunodeficiency virus.
    Everson-Mays RE; Weidle PJ
    Am J Health Syst Pharm; 1997 Jul; 54(13):1545-50. PubMed ID: 9217946
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cerebral toxoplasmosis in HIV infected patients intolerant of cotrimoxazole].
    Rabaud C; May T; Beuscart C; Reynes J; Leport C; Canton P
    Ann Med Interne (Paris); 1998 Mar; 149(2):62-6. PubMed ID: 11490526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMP-SMX desensitization.
    Posit Aware; 1995; ():7. PubMed ID: 11362574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and management of HIV-associated drug hypersensitivity.
    Carr A; Cooper DA
    AIDS Clin Rev; 1995-1996; ():65-97. PubMed ID: 7488561
    [No Abstract]   [Full Text] [Related]  

  • 15. [Syncitia inducing phenotype, zidovudine++ resistance and fast clinical progression in a child infected by HIV].
    Mellado Peña MJ; Villota Arrieta J; Bernal Zamora A; Cilleruelo Ortega MJ; García López M; Barreiro Casal G; Pérez Jurado ML; Martín Fontelos P
    An Esp Pediatr; 1997 Jan; 46(1):65-8. PubMed ID: 9082891
    [No Abstract]   [Full Text] [Related]  

  • 16. Study finds NAC fails to prevent Bactrim/Septra hypersensitivity.
    TreatmentUpdate; 1999 Feb; 11(1):4-5. PubMed ID: 11366023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocystis carinii pneumonia treatment in people infected with HIV.
    Bellamy R
    Clin Evid; 2004 Jun; (11):935-50. PubMed ID: 15652046
    [No Abstract]   [Full Text] [Related]  

  • 18. Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit.
    Chierakul W; Anunnatsiri S; Chaowagul W; Peacock SJ; Chetchotisakd P; Day NP
    Clin Infect Dis; 2007 Aug; 45(4):521-3. PubMed ID: 17638209
    [No Abstract]   [Full Text] [Related]  

  • 19. Pneumocystis pneumonia in people with HIV.
    Bellamy R
    Clin Evid; 2006 Jun; (15):982-95. PubMed ID: 16973040
    [No Abstract]   [Full Text] [Related]  

  • 20. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ.
    Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR;
    J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.